Peptinovo offers a targeted drug-delivery platform Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), a serious side effect. PALM delivers higher doses of existing, proven drugs into tumors, keeping them away from healthy tissues. Lives are extended and side effects avoided.
Cantilever has invested in a SAFE agreement with this company.
www.peptinovo.com
Cantilever has invested in a SAFE agreement with this company.
www.peptinovo.com
Investors 2
| Date | Name | Website |
| - | Cantilever... | cantilever... |
| - | ID Venture... | idventures... |
Mentions in press and media 1
| Date | Title | Description |
| - | PEPTINOVO BIOPHARMA | “Peptinovo Biopharma Inc. – Improving Cancer Survival Through Smart Drug Delivery” |